FDA.reportPublic FDA data

1 ML octreotide 0.05 MG/ML Injection [Sandostatin]

RxCUI
207194
RxNorm name
1 ML octreotide 0.05 MG/ML Injection [Sandostatin]
Display name
1 ML octreotide 0.05 MG/ML Injection [Sandostatin]
Full name
1 ML octreotide 0.05 MG/ML Injection [Sandostatin]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SandostatinOCTREOTIDE ACETATENovartis Pharmaceuticals Corporation4e2c9856-1836-49f0-9472-4dbeeb408f392026-07-22Warnings, Adverse reactionsExact identifier
rxcui: 207194

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4e2c9856-1836-49f0-9472-4dbeeb408f39SandoSTATIN 50 MCG in 1 ML Injection [PSN] · 1 ML octreotide 0.05 MG/ML Injection [Sandostatin] [SBD] · 1 ML Sandostatin 0.05 MG/ML Injection [SY]322These highlights do not include all the information needed to use SANDOSTATIN INJECTION safely and effectively. See full prescribing information for SANDOSTATIN INJECTION. SANDOSTATIN ® (octreotide acetate) INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 198820250811